Cytomx Therapeutics Stock Forecast

Sell candidate since Jul 21, 2026 Loss -2.63%

No changes to the price of CytomX Therapeutics stock on the last trading day (Thursday, 23rd Jul 2026). During the last trading day the stock fluctuated 3.97% from a day low at $3.28 to a day high of $3.41. The price has fallen in 8 of the last 10 days and is down by -15.8% for this period.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -13.63% during the next 3 months and, with a 90% probability hold a price between $2.26 and $3.33 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CTMX Signals & Forecast

There are few to no technical positive signals at the moment. The CytomX Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $3.51 and $3.38. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -15.80%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while price remained unchanged. This may be an early warning, but it may also not. We still recommend that you pay attention over the next couple of days.

Support, Risk & Stop-loss for CytomX Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.98 and $2.95. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, CytomX Therapeutics finds support just below today's level at $2.98. If this is broken, then the next support from accumulated volume will be at $2.95 and $2.93.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.130 between high and low, or 3.97%. For the last week, the stock has had daily average volatility of 4.65%.

CytomX Therapeutics is oversold on RSI14 (21). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CTMX) For The Upcoming Trading Day Of Friday 24th

For the upcoming trading day on Friday, 24th we expect CytomX Therapeutics to open at $3.34, and during the day (based on 14 day Average True Range), to move between $3.23 and $3.43, which gives a possible trading interval of +/-$0.196 (+/-6.06%) up or down from last closing price. If CytomX Therapeutics takes out the full calculated possible swing range there will be an estimated 6.06% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $3.40 (2.10%) than the support at $2.98 (10.51%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is CytomX Therapeutics stock A Buy?

CytomX Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.353 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 24, 2026 - $3.34 ( 0.200%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk